Latest round

Series B

Last raised

Nov 2024

Total raised

$40M

Investors

8

About Mevo

Nexodata do Brasil Ltda. is a Brazil-based company that develops innovative digital health solutions, focusing on streamlining healthcare processes for patients, providers, and pharmacies through its integrated platform. Founded in 2017 by Lucas Lacerda and Pedro Dias, Mevo Tecnologia Ltda. Mevo offers an integrated health platform designed to simplify healthcare experiences for patients, healthcare providers, and pharmacies. Their core products include Mevo Receita Digital, a digital prescription system that enables healthcare professionals to issue prescriptions electronically, and Mevo Farma, an online pharmacy service facilitating the purchase and delivery of medication. The platform specifically addresses challenges such as the cumbersome process of obtaining paper prescriptions, the need for medical histories, and the inconvenience of purchasing medications, particularly due to lost prescriptions. Mevo's services cater primarily to residents of the Greater São Paulo area, targeting a diverse user base that includes patients, doctors, hospitals, clinics, and pharmacies, aiming to make healthcare more accessible and efficient. Mevo generates revenue through transaction-based models that involve both direct-to-consumer sales and partnerships with healthcare providers and pharmacies. Their business model includes enabling healthcare professionals to utilize Mevo Receita Digital to streamline the prescription process, thereby increasing patient engagement and facilitating medication purchases through Mevo Farma. The transactions are characterized by direct sales from patients purchasing medications online or at partnered pharmacies. In this structure, healthcare providers may refer patients to the Mevo platform for prescription services, while pharmacies receive prescriptions digitally, ensuring a seamless experience for end users. The revenue streams are diversified, leveraging both the convenience offered to patients and the collaborative relationships built with healthcare partners. Mevo aims to expand its product offerings and geographic reach in the coming years. The company is focused on designing new features for Mevo Receita Digital to enhance user experience and is exploring expansion into additional Brazilian markets beyond Greater São Paulo.

Who invested in Mevo

8 investors across 4 rounds

See all investors in Mevo

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Nov 28, 2024

    Amount

    $5M

    Investors

    Locked

  2. Series B

    Sep 18, 2024

    Amount

    $20M

    Investors

    Locked

  3. Series A

    Jul 14, 2022

    Amount

    $8.4M

    Investors

    Locked

  4. Series A

    Jul 8, 2021

    Amount

    $6.7M

    Investors

    Locked

Questions about Mevo

Who invested in Mevo?

Mevo has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Mevo raised?

Mevo has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Mevo last raise money?

Mevo's most recent round on record is a Series B, in Nov 2024.

What does Mevo do?

Mevo is a healthcare it company.

Where is Mevo headquartered?

Mevo is headquartered in Sao Paulo, Brazil.

Which VCs invest in companies like Mevo?

Among active investors with capital left to deploy, Crescera Capital, Kaszek Ventures, Anti Fund and Kinea Investments back healthcare it companies at Mevo's stage. Their profiles are linked below.

Raising like Mevo? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.